Infographic: Biologic or Biosimilar? It doesn’t matter which

Description

This section includes videos and an infographic in English and Spanish that can be downloaded or printed (in color or black and white) and used in shared decision-making with patients. These materials provide the basic facts about biosimilars in the treatment of IBD and how they compare to the originator biologics in short, simple formats plus a list of references for those who may want to dig deeper.

Disclosures

Ikuo Hirano, MD

Research: Adare/Ellodi, Allakos, Arena, AstraZeneca, Meritage, Celgene/Receptos/BMS, Regeneron/Sanofi, and Shire/Takeda
Consulting: Adare/Ellodi, Allakos, Amgen, Arena, AstraZeneca, Celgene/Receptos/BMS, Eli Lilly, EsoCap, Gossamer Bio, Parexel/Calyx, Phathom, Regeneron, Sanofi, and Shire/Takeda

Glenn T. Furuta, MD

Research: NIH, Arena, Holoclara
Founder: EnteroTrack

Nirmala P. Gonsalves, MD

Consulting: Allakos, Astra-Zeneca, Sanofi-Regeneron, Abbvie, Knopp, Takeda
Speaking: Takeda
Up-to-Date: Royalties

Sponsors:

This educational offering is supported by Pfizer and Amgen.

	Title	Credit(s)
1	Welcome (0 votes) View Details
2	Biosimilars Health Care Provider Video (0 votes) View Details
3	Biosimilars Patients Video (English) (0 votes) View Details
4	Biosimilars Patients Video (Spanish) (0 votes) View Details
5	Biosimilars Infographic in English (0 votes) View Details